The antitrust authority in the EU revealed that its decision on German pharmaceutical giant Bayer’s €7.3bn (US$6.4bn) acquisition of Aventis’ agrochemical unit will be delayed by one week.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
EU spokesman Michael Tscherny told Dow Jones on Friday: “We aren’t ready yet [to make a decision] and there are ongoing contacts with the companies.”
The decision had been expected tomorrow [Tuesday] but now will arrive on 17 April. The EU authorities must announce its decision by 22 April by law.
